Sorry for people losing money on this, looks like 25 is next stop now.
I went back to NYMX 1 year chart to see the drop in late Oct from $5 to $.80cents and read the article on why it crashed. Seems it was basically the same reason SPHS crashed in Dec.
This stock SPHS will soar once the study is completed and positive results come in. Risk vs Reward is why I'm here. Its more than worth the risk as you can easily see a 100% to 200% gain in one day. This could be $50.00 in a few years time. Just be patient.
Below is excerpt from the article on NYMX late Oct 2014.
after the company NYMX announced the failure of its enlarged prostate drug to meet the primary endpoints in the Phase II studies Sunday. The drug candidate, NX-1207, is a novel treatment that is being evaluated against benign prostatic hyperplasia (BPH), or simply prostate enlargement.
Break Even or Profit to be made on Earnings Aug 6 which is approaching quickly. Dirt cheap for the potential this company has in the future. Potential cure for Prostate Cancer and BPH, (Enlarged Prostate). How could the market cap only be $12.6 million is beyond me. A very low float of shares (16.8million) means when positive news comes out, this goes up very, very quickly. Take advantage soon or you will miss the boat.
Get your buy orders in the cheap stocks in the next few days. Maybe some more to drop. But in the months ahead, it all becomes history and we continue on as if nothing ever happened. Funny how it works. The time to buy is when there is fear. We have learned that lesson many times over and over again.
did he check out at .40 cents... Wow, what a pump, from .20 to .40 in 4 weeks, then down again. Cant even walk away from the laptop these days.
-.09 to .96 AH last night. They want your shares. Just close the laptop and come back in a few months. You'll be glad you did. Hold your shares and don't worry about it. That's how long investors make money.
Who bought at 7.20?
Tuesday July 9th was the 10th trading day the bid closed at $1.00 or more. May 27, 28, 28, June 1,2,3,4,5,8,9
Quite obvious on Tuesday afternoon, they tried to take it down below a dollar but it was too much for them and they couldn't do it.
I've read through all the clinical trials tonight on Sophiris Web site and in my mind, this stock is way over sold. The drug (PRX302) has already been proven to work in their 6 completed clinical trials. There are 2 on going trials, 1 in the UK called (Plus 1-Phase III Trial( to be completed second half of 2015.
The stock sold off in Dec 2014 because of a minor miss by an Independent Data Monitoring Committee (IDMC) saying The IDMC reported that the predefined efficacy threshold at Week 12 was not achieved.
But the next sentence states,
This administrative interim analysis was conducted specifically for planning subsequent clinical trials. All patients in the study will continue to be followed to enable the evaluation of the primary efficacy endpoint at 52 weeks.
Again, the drug PRX302 is already proven to work for BPH with no side effects and 2 or 6 patience with Prostate Cancer.
Read the clinical trials on their website.
Sooner or later, this is going up, way up, no question in my mind. GL to All.